Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25,854 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development of National Cancer Database for Cost and Quality of Life (CaDCQoL) in India: a protocol.
Prinja S, Dixit J, Gupta N, Mehra N, Singh A, Krishnamurthy MN, Gupta D, Rajsekar K, Kalaiyarasi JP, Roy PS, Malik PS, Mathew A, Pandey A, Malhotra P, Gupta S, Kumar L, Kataki A, Singh G. Prinja S, et al. Among authors: singh g, singh a. BMJ Open. 2021 Jul 29;11(7):e048513. doi: 10.1136/bmjopen-2020-048513. BMJ Open. 2021. PMID: 34326050 Free PMC article.
Cost Effectiveness of Bevacizumab Plus Chemotherapy for the Treatment of Advanced and Metastatic Cervical Cancer in India-A Model-Based Economic Analysis.
Gupta N, Nehra P, Chauhan AS, Mehra N, Singh A, Krishnamurthy MN, Rajsekhar K, Kalaiyarasi JP, Roy PS, Malik PS, Mathew A, Malhotra P, Kataki AC, Dixit J, Gupta S, Kumar L, Prinja S. Gupta N, et al. Among authors: singh a. JCO Glob Oncol. 2022 Mar;8:e2100355. doi: 10.1200/GO.21.00355. JCO Glob Oncol. 2022. PMID: 35286136 Free PMC article.
Cost Effectiveness of Ribociclib and Palbociclib in the Second-Line Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer in Post-Menopausal Indian Women.
Gupta N, Gupta D, Dixit J, Mehra N, Singh A, Krishnamurthy MN, Jyani G, Rajsekhar K, Kalaiyarasi JP, Roy PS, Malik PS, Mathew A, Malhotra P, Gupta S, Kumar L, Kataki A, Prinja S. Gupta N, et al. Among authors: singh a. Appl Health Econ Health Policy. 2022 Jul;20(4):609-621. doi: 10.1007/s40258-022-00731-2. Epub 2022 May 10. Appl Health Econ Health Policy. 2022. PMID: 35534752
Cost-effectiveness analysis of different combination therapies for the treatment of chronic lymphocytic leukaemia in India.
Nehra P, Chauhan AS, Malhotra P, Kumar L, Singh A, Gupta N, Mehra N, Mathew A, Kataki AC, Gupta S, Prinja S. Nehra P, et al. Among authors: singh a. Lancet Reg Health Southeast Asia. 2023 May 2;13:100201. doi: 10.1016/j.lansea.2023.100201. eCollection 2023 Jun. Lancet Reg Health Southeast Asia. 2023. PMID: 37383548 Free PMC article.
Financial toxicity of cancer treatment in India: towards closing the cancer care gap.
Prinja S, Dixit J, Gupta N, Dhankhar A, Kataki AC, Roy PS, Mehra N, Kumar L, Singh A, Malhotra P, Goyal A, Rajsekar K, Krishnamurthy MN, Gupta S. Prinja S, et al. Among authors: singh a. Front Public Health. 2023 Jun 19;11:1065737. doi: 10.3389/fpubh.2023.1065737. eCollection 2023. Front Public Health. 2023. PMID: 37404274 Free PMC article.
Outcomes in Treatment-Naïve Patients With Metastatic Extremity Osteosarcoma Treated With OGS-12, a Novel Non-High-Dose Methotrexate-Based, Dose-Dense Combination Chemotherapy, in a Tertiary Care Cancer Center.
Bajpai J, Chandrasekharan A, Simha V, Talreja V, Karpe A, Pandey N, Singh A, Rekhi B, Vora T, Ghosh J, Banavali S, Gupta S. Bajpai J, et al. Among authors: singh a. J Glob Oncol. 2018 Sep;4:1-10. doi: 10.1200/JGO.17.00137. J Glob Oncol. 2018. PMID: 30241240 Free PMC article.
25,854 results
You have reached the last available page of results. Please see the User Guide for more information.